A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes

New England Journal of Medicine

Volumn 335, Issue 11, 1996, Pages 775-782

  Topol, E ^a   Califf, R ^a   Granger, C ^a   Van De Werf, F ^a   Aylward, P ^a   Simes, J ^a   Col, J ^a   Armstrong, P ^a   Vahanian, A ^a   Neuhaus, K ^a   Rutsch, W ^a,a   Ardissino, D ^a   Simoons, M ^a   White, H ^a   Betriu, A ^a   Emanuelsson, H ^a   Pfisterer, M ^a,a   Beatt, K ^a   Bates, E ^a   Cheseboro, J ^a   Ellis, S ^a   Fuster, V ^a   Gibler, W ^a   Gore, J ^a   Guerci, A ^a   Hochman, J ^a   Holmes, D ^a   Kleiman, N ^a   Morris, D ^a,a   Ohman, M ^a   Phillips, H ^a   Weaver, D ^a   Miller, G ^a   Bahr, R ^a   Worley, S ^a   Schrading, W ^a   Gilchrist, I ^a   Ibarra, J ^a   Krishnaswami, V ^a   Nygaard, T ^a   Dageforde, D ^a   Puma, J ^a   Palmeri, S ^a   Rosing, D ^a   Dale, H ^a   Boyek, T ^a   Morrice, B ^a   Weinberg, S ^a   Noble, W ^a   VanGilder, J ^a   O Toole, J ^a   Jesse, R ^a   Loss, D ^a   Wertheimer, J ^a   Ferrari, D ^a   Santer, M ^a   Strahan, N ^a   Schaeffer, J ^a   Avington, M ^a   Miller, R ^a,a   Eich, D ^a   Vrobel, T ^a   Kerieakes, D ^a   Sharma, S ^a   Beckwith, W ^a   Micale, P ^a   Polinski, W ^a   Goodfield, P ^a   Paraschos, A ^a   Chandler, A ^a   Talley, J ^a   Morse, H ^a   Sheridan, F ^a   Silverman, M ^a   Baga, V ^a   Ware, J ^a   Seagle, R ^a   Maddox, W ^a   Schrank, J ^a   Gainey, P ^a   Iwaoka, R ^a   Schneider, R ^a   Ingram, R ^a   Hanger, K ^a   Lane, G ^a   Beeson, W ^a   Williams, D ^a   Beasley, C ^a   Spriggs, D ^a   Schlant, R ^a   Sullebarger, J ^a   Smith, J ^a   Mishkel, D ^a   Williams, C ^a   Gibbs, K ^a   Hearon, B ^a   Gonzales, M ^a   Sheikh, K ^a   Dedonis, J ^a   Long, T ^a   Popio, K ^a   Jamal, N ^a   Lambrew, C ^a   Labib, S ^a   Vorchheimer, D ^a   Weiss, R ^a   Mercadante, N ^a   Guerei, A ^a   Rashkow, A ^a   Balleli, L ^a   Gacioch, G ^a   Niles, N ^a   Seidenstein, H ^a   Hollander, G ^a   Wallach, R ^a   Khan, A ^a   Graham, S ^a   Simons, A ^a   Ward, H ^a   Parkes, R ^a   Watkins, M ^a   DeLuccia, W ^a   Urbach, D ^a   Grodman, R ^a   McCord, D ^a   Bleiberg, M ^a   Corbelli, J ^a   Pepe, A ^a   Zwerner, P ^a   Pinsky, L ^a   Petrovich, L ^a   Lindenberg, B ^a   Therrien, M ^a   Sands, M ^a   Rosenfeld, A ^a   Sheikh, S ^a   Riba, A ^a   Hanovich, G ^a   Swenson, L ^a   Holland, K ^a   Schmidt, P ^a   Besley, D ^a   Hession, W ^a   Ferrigni, F ^a   Meyers, D ^a   Duvernoy, W ^a   Abramowitz, B ^a   Stomel, R ^a   Becker, J ^a   Mooss, A ^a   Thompson, J ^a   Calli, L ^a   Penilla, A ^a   McCriskin, J ^a   Millsaps, R ^a   Heinsimer, J ^a   Pfefferkorn, D ^a   Saddin, M ^a   Fintel, D ^a   Harner, R ^a   Kopecky, S ^a   Andres, P ^a   Cook, L ^a   Wefald, F ^a   Vanderlaan, R ^a   Love, J ^a   Zands, M ^a   Santolin, C ^a   Arnold, A ^a   Oatfield, R ^a   Jaeger, K ^a   Dean, E ^a   Swenson, R ^a   Lancaster, L ^a   Raskin, S ^a   Fehrenbacher, G ^a   Lombardo, T ^a   Strunk, B ^a   Perry, J ^a   Lai, P ^a   Rowe, W ^a   Symkoviak, G ^a   Lee, H ^a   Kwee, H ^a   Woolbert, S ^a   Kaplan, J ^a   Titus, B ^a   Wolfe, C ^a   Cislowski, D ^a   Berndt, T ^a   White, R ^a   Brown, D ^a   Hill, D ^a   Hui, G ^a   Spiegel, R ^a   Wesley, G ^a   Mattern, A ^a   Lapin, E ^a   Stern, M ^a   Kraus, M ^a   Olson, H ^a   Scott, R ^a   MacKenzie, B ^a   Hui, W ^a   Roth, S ^a   Goode, E ^a   Burton, J ^a   Senaratne, M ^a   Traboulsi, M ^a   Greenwood, P ^a   Morgan, C ^a   Ervin, F ^a   McDowell, J ^a   Lefkowitz, C ^a   Sauve, M ^a   Turek, M ^a   Finnie, K ^a   Kuruvilla, G ^a   Langer, A ^a   Charles, J ^a   Kells, C ^a   Vizel, S ^a   Baillie, H ^a   Sahay, B ^a   Roth, D ^a   Lubelsky, B ^a   Jablonsky, G ^a   Lesoway, R ^a   Kwok, K ^a   MacMillan, C ^a   Adelman, A ^a   Labinaz, M ^a   Guagliumi, G ^a   Branzi, A ^a   Galvani, M ^a   Mafrici, A ^a   Savonitto, S ^a   Fornaro, G ^a   Colombi, E ^a   Zanuttini, D ^a   Ottani, F ^a   Cavallini, C ^a   Camerini, F ^a   Repetto, S ^a   Vassanelli, C ^a   Rovelli, E ^a   Polese, A ^a   Politi, A ^a   Capucci, A ^a   Mambelli, M ^a   Sabate X ^a   Masia R ^a   Lopez Bescos L ^a   Lopez Sendon J ^a   Jodar L ^a   Rodriquez Llorian, A ^a   Martin Luengo C ^a   Saenz, L ^a   Fernandez Aviles, F ^a   Froufe, J ^a   Loma Osorio, A ^a   Bayon J ^a   Jeffrey, I ^a   Nelson, G ^a   Walsh, W ^a   Leitch, J ^a   Campbell, T ^a   Healey, J ^a   Owensby, D ^a   Ramsey, D ^a   Grigg, L ^a   Ferderman, J ^a   Newman, R ^a   Strickland, J ^a   Lim, P ^a   Counsell, J ^a   Cross, D ^a   Garrahy, P ^a   Coverdale, S ^a   Bett, N ^a   Aroncy, G ^a   Brown, M ^a   Simmons, G ^a   Horowitz, J ^a   Thompson, P ^a   Hockings, B ^a   Hendricks, R ^a   Thomson, A ^a   Rankin, R ^a,a   Bouma, H ^a   Cozynsen, L ^a   Stolwijk, P ^a   Drost, H ^a   Van Kalmthout, P ^a   Engbers, J ^a   Westendorp, P ^a   Voorburg, J ^a   Veerhoek, M ^a   Pao Han, T ^a   Bogerijen, L ^a   Ramdat Misier, A ^a   Bosker, H ^a   Smits, W ^a   Tan, T ^a   Castadot, M ^a   Installe E ^a   De Meester, A ^a   Boland, J ^a   Legrand, V ^a   Vanwelden, J ^a   Pirenne, B ^a   Emmerechts, C ^a   Beeuwsaert, R ^a   Thiels, H ^a   Beckers, J ^a   Lesseliers, H ^a   Popeye, R ^a   Quiret, J ^a   Maroni, J ^a   Farah, B ^a   Etienne, Y ^a   Funck, F ^a   Tran Thanh, X ^a   Khalife, K ^a   Leclercq, F ^a   Vitoux, B ^a   Cohen, A ^a   Vacheron, A ^a   Barreau, D ^a   Simon, R ^a   Kreft, H ^a   Ditter, H ^a   Zeiher, A ^a   Weizner, M ^a   Wacker, R ^a   Marbach, M ^a   Nast, H ^a   Meyer Hofmann, H ^a   Schmitz Hubner U ^a   Bode, M ^a   Maisch, B ^a   Topp, H ^a   Lollgen H ^a   Williams, M ^a   Durham, D ^a   Bruns, B ^a   Hayes, D ^a   Leslie, P ^a   Hart, H ^a   Ikram, H ^a   Mann, S ^a   Kirk, A ^a   Jardine, D ^a   Audeau, M ^a   Anandaraja, S ^a   Cooper, I ^a   Hogan, J ^a   Hackett, D ^a   Travill, C ^a   Bridgon, G ^a   Burrell, C ^a   Debelder, M ^a   Rozkovec, A ^a   Kooner, J ^a   James, M ^a   Garcia, E ^a   Risenfors, M ^a   Baur, H ^a   Urban, P ^a   Mocetti, T ^a   Angehrn, W ^a   Bertel, O ^a   Amann, F ^a   more..

^a NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DESULFATOHIRUDIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LEPIRUDIN; NITRATE; THROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART INFARCTION; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

EID: 0029835392     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609123351103     Document Type: Article

References (32)

1. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82:Suppl II:II-38-II-46.
2. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988;77:1213-20.
3. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
4. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-46. [Erratum, Circulation 1995;91:256.]
5. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
6. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994;89:1545-56.
7. Topol EJ, Fuster V, Harrington RA, et al. Recombinant hirudin for unstable angina pectoris: a multicenter, randomized angiographic trial. Circulation 1994;89:1557-66.
8. Cannon CP, McCabe CH, Henry TD, et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol 1994;23:993-1003.
9. Lee LV. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial. Am J Cardiol 1995;75:7-13.
10. Lefkovits J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation 1994;90:1522-36
11. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
12. Granger CB, Hirsch J, Califf RM, et al. Activated partial thrombo plastin time and outcome after thrombolycic therapy for acute myocardial infarction: results from the GUSTO-1 trial. Circulation 1996;93: 870-8.
13. Granger CB, Miller JM, Bovill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995;91:1929-35.
14. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994; 90:1631-7
15. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
16. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7.
17. DeMets DL, Ware JH. Group sequential methods for clinical trials with a one-sided hypothesis. Biometrika 1980;67:651-60.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
19. Antman EM. Antiplatelet/antithrombotic agents: Plenary Seminar, Joint AHA/European Society of Cardiology Symposium: contemporary treatment strategies for acute myocardial infarction. Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, Calif., November 13, 1995. abstract.
20. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Comparison of hirudin with heparin and warfarin with control for unstable angina and non Q wave MI in a randomized controlled trial. Circulation 1995;92:Suppl I:I-416. abstract.
21. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
22. Lincoff AM. Evaluation of PTCA to improve long-term outcomes by c7E3 glycoprotein IIb/IIIa receptor blockade (EPILOG). Presented at the American College of Cardiology (ACC) Symposia 622: Major Clinical Trials V: Interventional Therapy, Orlando, Fla., March 27, 1996. abstract.
23. Simoons ML. Review of the chimeric 7E3 antiplatelet in unstable angina refractory to standard treatment (CAPTURE) trial. Presented at the American College of Cardiology (ACC) Symposia 602: Major Clinical Trials V: Interventional Therapy, Orlando, Fla., March 25, 1996. abstract.
24. Coller BS. The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy. Eur Heart J 1995;16:Suppl L:11-5.
25. Serruys PW, Herrman J-PR, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995;333:757-63.
26. Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-9.
27. Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996;347:561-8.
28. Zoldhelyi P, Janssens S, Lefèvre G, Collen D, Van de Werf F. Effects of heparin and hirudin (CGP 39393) on thrombin generation during thrombolysis for acute myocardial infarction. Circulation 1995;92:Suppl I: I-740. abstract.
29. Merlini PA, Ardissino D, Bauer KA, et al. Persistent thrombin generation during heparin treatment in patients with acute coronary syndromes. Circulation 1995;92:Suppl I:I-623. abstract.
30. Flather M, Weitz J, Campeau J, et al. Evidence for rebound activation of the coagulation system after cessation of intravenous anticoagulant therapy for acute myocardial ischemia. Circulation 1995;92:Suppl I:I-485. abstract.
31. Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation 1994;89:1802-9.
32. Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995;332:1374-6. The New England Journal of Medicine September 12, 1996